Detailed view for PBANKA_1014500

Basic information

TDR Targets ID: 828289
Plasmodium berghei, plasmepsin IX, putative
Source Database / ID: 

pI: 9.6025 | Length (AA): 607 | MW (Da): 71451 | Paralog Number: 1

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1

Druggability Group : DG

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00026   Eukaryotic aspartyl protease

Gene Ontology

Mouse over links to read term descriptions.
GO:0004190   aspartic-type endopeptidase activity  
GO:0006508   proteolysis  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 3 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
32 194 2qyu (A) 433 593 10.00 0 0.02 0.309134 -0.41
154 585 1pfz (A) 91 325 25.00 0 1 0.665297 0.88
200 287 4od9 (A) 7 94 43.00 0.000000000064 0.99 0.595875 0.29

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile Gametocyte, Ookinete, 22 hs Schizont, Male gametocyte. Otto TD Yeoh LM
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile 4 hs Ring, Female gametocyte. Otto TD Yeoh LM
Upregulation Percent Ranking Stage Dataset
Lower 0-20% percentile 16 hs Trophozoite, Erthyrocytic stages. Otto TD Yeoh LM
Show/Hide expression data references
  • Yeoh LM Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates.
  • Otto TD A comprehensive evaluation of rodent malaria parasite genomes and gene expression.

Orthologs

Ortholog group members (OG5_133546)

Species Accession Gene Product
Babesia bovis BBOV_IV007890   aspartyl protease, putative
Cryptosporidium parvum cgd6_660   secreted pepsinogen like aspartyl protease having a signal peptide
Homo sapiens 643834   pepsinogen 3, group I (pepsinogen A)
Homo sapiens 101929842   pepsin A-3-like
Homo sapiens 643847   pepsinogen 4, group I (pepsinogen A)
Homo sapiens ENSG00000256713   pepsinogen 5, group I (pepsinogen A)
Mus musculus ENSMUSG00000046213   chymosin
Neospora caninum NCLIV_063340   hypothetical protein
Plasmodium berghei PBANKA_1222500   plasmepsin X
Plasmodium berghei PBANKA_1014500   plasmepsin IX, putative
Plasmodium falciparum PF3D7_0808200   plasmepsin X
Plasmodium falciparum PF3D7_1430200   plasmepsin IX
Plasmodium knowlesi PKNH_0110500   eukaryotic aspartyl protease, putative
Plasmodium knowlesi PKNH_1328500   aspartyl protease, putative
Plasmodium vivax PVX_088125   aspartyl protease, putative
Plasmodium vivax PVX_085030   aspartyl protease, putative
Plasmodium yoelii PY01268   pepsinogen A-related
Plasmodium yoelii PY06692   Eukaryotic aspartyl protease, putative
Toxoplasma gondii TGME49_246550   aspartyl protease ASP3
Theileria parva TP03_0307   hypothetical protein

Essentiality

PBANKA_1014500 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
PBANKA_1014500 this record Plasmodium berghei Essential plasmo
PBANKA_1222500 Plasmodium berghei Essential plasmo
TGME49_246550 Toxoplasma gondii Essentiality uncertain sidik
Show/Hide essentiality data references
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Species Known druggable target Linked compounds Reference
Homo sapiens pepsinogen 5, group I (pepsinogen A) Compounds References
Sus scrofa Pepsin A Compounds References
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Plasmodium falciparum plasmepsin III 451 aa 23.2% 400 aa Compounds References
Bos taurus Cathepsin D 390 aa 25.8% 403 aa Compounds References
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PBANKA_1014500 (Plasmodium berghei), plasmepsin IX, putative
Title for this comment
Comment